U.S. Food and Drug Administration (FDA): Remote or Wearable Patient Monitoring Devices EUAs

Remote or wearable patient monitoring devices help the clinicians retrieve information and provide care to the patients remotely. These devices facilitate the detection of common physiological parameters and wireless transmission of patient health data to the concerned healthcare provider. The issuance of EUAs for specific remote monitoring devices by the FDA has accelerated these devices’ availability, thereby reducing the provider’s exposure to COVID-19. Examples of remote monitoring devices include fitbit, blood pressure monitors, continuous blood glucose monitors, heart rate monitors, oximeters, smart scales, etc. All these devices are essential for improving healthcare quality and play a critical role in reducing hospital readmissions.